Massimo Marignani
Overview
Explore the profile of Massimo Marignani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morisco F, Federico A, Marignani M, Lombardo F, Cossiga V, Ranieri L, et al.
Viruses
. 2024 Sep;
16(9).
PMID: 39339915
The prediction of liver-related events (LRE) after sustained virological response (SVR) in HCV-advanced chronic liver disease (ACLD) patients is crucial. We aimed to evaluate incidence and risk factors of LRE...
2.
De Vincentis A, Ampuero J, Terracciani F, DAmato D, Gerussi A, Cristoferi L, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(10):2062-2074.e11.
PMID: 38782175
Background & Aims: Obeticholic acid (OCA) is the only licensed second-line therapy for primary biliary cholangitis (PBC). With novel therapeutics in advanced development, clinical tools are needed to tailor the...
3.
Biselli M, Reggidori N, Iavarone M, Renzulli M, Lani L, Granito A, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539416
Background And Aims: Sarcopenia has been associated with poor outcomes in patients with cirrhosis and hepatocellular carcinoma. We investigated the impact of sarcopenia on survival in patients with advanced hepatocellular...
4.
Salpini R, Piermatteo L, Torre G, DAnna S, Khan S, Duca L, et al.
Int J Infect Dis
. 2023 Nov;
138:1-9.
PMID: 37944585
Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its fluctuations over time and we provide an extensive characterization of HDV-infected patients. Methods: The rate of HDV seroprevalence...
5.
Piermatteo L, DAnna S, Bertoli A, Bellocchi M, Carioti L, Fabeni L, et al.
Emerg Microbes Infect
. 2023 Jun;
12(1):2219347.
PMID: 37288750
Specific HBsAg mutations are known to hamper HBsAg recognition by neutralizing antibodies thus challenging HBV-vaccination efficacy. Nevertheless, information on their impact and spreading over time is limited. Here, we characterize...
6.
Stroffolini T, Ciancio A, Federico A, Benigno R, Colloredo G, Lombardi A, et al.
Eur J Clin Microbiol Infect Dis
. 2023 May;
42(8):945-950.
PMID: 37169944
To date, few reports have evaluated the pneumococcal vaccination status in cirrhotic patients. No data are available for European countries. We have explored this topic and the potential independent predictors...
7.
Roberto M, Panebianco M, Aschelter A, Buccilli D, Cantisani C, Caponnetto S, et al.
Front Oncol
. 2023 Jan;
12:1026978.
PMID: 36713496
The new landscape of treatments for metastatic clear cell renal carcinoma (mRCC) is constantly expanding, but it is associated with the emergence of novel toxicities, adding to up to those...
8.
Stroffolini T, Ciancio A, Federico A, Benigno R, Colloredo G, Lombardi A, et al.
Dig Liver Dis
. 2022 Dec;
55(3):316-321.
PMID: 36529636
Background And Aims: Few reports, all retrospective, have evaluated vaccine coverage against COVID-19 infection in cirrhotic subjects. No data are available for European Countries. We aimed to explore this topic...
9.
Zannella A, Fanella S, Marignani M, Begini P
World J Hepatol
. 2022 Feb;
14(1):274-286.
PMID: 35126854
Background: In December 2019, the coronavirus disease-2019 (COVID-19) emerged and rapidly spread worldwide, becoming a global health threat and having a tremendous impact on the quality of life (QOL) of...
10.
Morisco F, Federico A, Marignani M, Cannavo M, Pontillo G, Guarino M, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359711
Background: Prospective studies on predictors of liver-related events in cirrhotic subjects achieving SVR after DAAs are lacking. Methods: We prospectively enrolled HCV cirrhotic patients in four Italian centers between November...